133 related articles for article (PubMed ID: 27775362)
21. Metal ion mediated transition from random coil to β-sheet and aggregation of Bri2-23, a natural inhibitor of Aβ aggregation.
Luczkowski M; De Ricco R; Stachura M; Potocki S; Hemmingsen L; Valensin D
Metallomics; 2015 Mar; 7(3):478-90. PubMed ID: 25633876
[TBL] [Abstract][Full Text] [Related]
22. Polyarginine and its analogues inhibit p53 mutant aggregation and cancer cell proliferation in vitro.
Chen Z; Chen J; Keshamouni VG; Kanapathipillai M
Biochem Biophys Res Commun; 2017 Jul; 489(2):130-134. PubMed ID: 28536076
[TBL] [Abstract][Full Text] [Related]
23. R248Q mutation--Beyond p53-DNA binding.
Ng JW; Lama D; Lukman S; Lane DP; Verma CS; Sim AY
Proteins; 2015 Dec; 83(12):2240-50. PubMed ID: 26442703
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of p53 protein aggregation as a cancer treatment strategy.
Kwan K; Castro-Sandoval O; Gaiddon C; Storr T
Curr Opin Chem Biol; 2023 Feb; 72():102230. PubMed ID: 36436275
[TBL] [Abstract][Full Text] [Related]
25. Hydrophobic side-chain size is a determinant of the three-dimensional structure of the p53 oligomerization domain.
McCoy M; Stavridi ES; Waterman JL; Wieczorek AM; Opella SJ; Halazonetis TD
EMBO J; 1997 Oct; 16(20):6230-6. PubMed ID: 9321402
[TBL] [Abstract][Full Text] [Related]
26. First-order rate-determining aggregation mechanism of p53 and its implications.
Wang G; Fersht AR
Proc Natl Acad Sci U S A; 2012 Aug; 109(34):13590-5. PubMed ID: 22869710
[TBL] [Abstract][Full Text] [Related]
27. The effect of mutations on peptide models of the DNA binding helix of p53: evidence for a correlation between structure and tumorigenesis.
Trulson JA; Millhauser GL
Biopolymers; 1999 Mar; 49(3):215-24. PubMed ID: 9990839
[TBL] [Abstract][Full Text] [Related]
28. A systematic molecular dynamics approach to the structural characterization of amyloid aggregation propensity of β2-microglobulin mutant D76N.
Chandrasekaran P; Rajasekaran R
Mol Biosyst; 2016 Mar; 12(3):850-9. PubMed ID: 26757617
[TBL] [Abstract][Full Text] [Related]
29. Elucidating the Mechanisms of R248Q Mutation-Enhanced p53 Aggregation and Its Inhibition by Resveratrol.
Liu Q; Li L; Yu Y; Wei G
J Phys Chem B; 2023 Sep; 127(36):7708-7720. PubMed ID: 37665658
[TBL] [Abstract][Full Text] [Related]
30. Effects of G33A and G33I mutations on the structures of monomer and dimer of the amyloid-β fragment 29-42 by replica exchange molecular dynamics simulations.
Lu Y; Wei G; Derreumaux P
J Phys Chem B; 2011 Feb; 115(5):1282-8. PubMed ID: 21186801
[TBL] [Abstract][Full Text] [Related]
31. Fluorescent Biosensor for Detection of the R248Q Aggregation-Prone Mutant of p53.
Pellerano M; Naud-Martin D; Mahuteau-Betzer F; Morille M; Morris MC
Chembiochem; 2019 Feb; 20(4):605-613. PubMed ID: 30548750
[TBL] [Abstract][Full Text] [Related]
32. Kinetic mechanism of p53 oncogenic mutant aggregation and its inhibition.
Wilcken R; Wang G; Boeckler FM; Fersht AR
Proc Natl Acad Sci U S A; 2012 Aug; 109(34):13584-9. PubMed ID: 22869713
[TBL] [Abstract][Full Text] [Related]
33. Model amyloid peptide B18 monomer and dimer studied by replica exchange molecular dynamics simulations.
Knecht V
J Phys Chem B; 2010 Oct; 114(39):12701-7. PubMed ID: 20839866
[TBL] [Abstract][Full Text] [Related]
34. Expanding the prion concept to cancer biology: dominant-negative effect of aggregates of mutant p53 tumour suppressor.
Silva JL; Rangel LP; Costa DC; Cordeiro Y; De Moura Gallo CV
Biosci Rep; 2013 Jul; 33(4):. PubMed ID: 24003888
[TBL] [Abstract][Full Text] [Related]
35. Distinct role of hydration water in protein misfolding and aggregation revealed by fluctuating thermodynamics analysis.
Chong SH; Ham S
Acc Chem Res; 2015 Apr; 48(4):956-65. PubMed ID: 25844814
[TBL] [Abstract][Full Text] [Related]
36. The (1-63) region of the p53 transactivation domain aggregates in vitro into cytotoxic amyloid assemblies.
Rigacci S; Bucciantini M; Relini A; Pesce A; Gliozzi A; Berti A; Stefani M
Biophys J; 2008 May; 94(9):3635-46. PubMed ID: 18199664
[TBL] [Abstract][Full Text] [Related]
37. Tyrosine Regulates β-Sheet Structure Formation in Amyloid-β
Coskuner O; Uversky VN
J Chem Inf Model; 2017 Jun; 57(6):1342-1358. PubMed ID: 28474890
[TBL] [Abstract][Full Text] [Related]
38. The transient manifold structure of the p53 extreme C-terminal domain: insight into disorder, recognition, and binding promiscuity by molecular dynamics simulations.
Fadda E; Nixon MG
Phys Chem Chem Phys; 2017 Aug; 19(32):21287-21296. PubMed ID: 28597880
[TBL] [Abstract][Full Text] [Related]
39. Mechanistic insight into the destabilization of p53TD tetramer by cancer-related R337H mutation: a molecular dynamics study.
Yu Y; Dong X; Tang Y; Li L; Wei G
Phys Chem Chem Phys; 2022 Feb; 24(8):5199-5210. PubMed ID: 35166747
[TBL] [Abstract][Full Text] [Related]
40. Rational design of mutations that change the aggregation rate of a protein while maintaining its native structure and stability.
Camilloni C; Sala BM; Sormanni P; Porcari R; Corazza A; De Rosa M; Zanini S; Barbiroli A; Esposito G; Bolognesi M; Bellotti V; Vendruscolo M; Ricagno S
Sci Rep; 2016 May; 6():25559. PubMed ID: 27150430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
